文献速递甲状腺疾病

分化型甲状腺癌的性别差异

Sex Differences in Differentiated Thyroid Cancer.
PubMed 文献 · Thyroid · 2022-01-01

甲状腺癌是唯一在女性中发病率显著高于男性的非生殖系统癌症,女性发病率高3-4倍,但男性患者病情通常更具侵袭性。该综述总结了性激素、遗传学和免疫系统在分化型甲状腺癌发病、进展及治疗反应中性别差异作用的新兴证据,指出目前治疗和监测未区分性别,需要性别特异性的防治策略。

要点

  • 甲状腺癌女性发病率是男性的3-4倍,但男性患者通常病情更具侵袭性。
  • 6-20%的甲状腺癌患者发生区域或远处转移,其中三分之一对常规治疗无反应,10年生存率仅10%。
  • 性激素、遗传学和免疫系统以性别特异的方式调节甲状腺癌风险和进展。

核心结论

  • 更深入理解甲状腺癌发病机制中性别差异的分子基础,可为开发性别特异、靶向且有效的预防、诊断和管理策略提供思路。

研究设计与样本

  • 这是一篇综述,总结关于性别在分化型甲状腺癌发病、进展和治疗反应中作用的新兴证据,重点阐述性激素、遗传学和免疫系统的作用。

主要发现

  • 甲状腺癌是唯一在女性中发病率显著高于男性的非生殖系统癌症,女性发病率高3-4倍,但男性患者病情通常更具侵袭性。
  • 尽管甲状腺癌总体预后良好,6-20%的患者发生区域或远处转移,其中三分之一对常规治疗无反应,10年生存率仅10%。
  • 酪氨酸激酶抑制剂和免疫治疗具有重大毒性,且未显示总生存获益。
  • 新兴证据表明性激素、遗传学和免疫系统以性别特异的方式调节甲状腺癌风险及其进展。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Sex dimorphism strongly impacts tumor biology, with most cancers having a male predominance. Uniquely, thyroid cancer (TC) is the only nonreproductive cancer with striking female predominance with three- to four-fold higher incidence among females, although males generally have more aggressive disease. The molecular basis for this observation is not known, and current approaches in treatment and surveillance are not sex specific. Summary: Although TC has overall good prognosis, 6-20% of patients develop regional or distant metastasis, one third of whom are not responsive to conventional treatment approaches and suffer a 10-year survival rate of only 10%. More efficacious treatment strategies are needed for these aggressive TCs, as tyrosine kinase inhibitors and immunotherapy have major toxicities without demonstrable overall survival benefit. Emerging evidence indicates a role of sex hormones, genetics, and the immune system in modulation of both risk for TC and its progression in a sex-specific manner. Conclusion: Greater understanding of the molecular mechanisms underlying sex differences in TC pathogenesis could provide insights into the development of sex-specific, targeted, and effective strategies for prevention, diagnosis, and management. This review summarizes emerging evidence for the importance of sex in the pathogenesis, progression, and response to treatment in differentiated TC with emphasis on the role of sex hormones, genetics, and the immune system.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Shobab L, Burman KD, Wartofsky L, et al. Sex Differences in Differentiated Thyroid Cancer. Thyroid. 2022. PMID: 34969307. doi:10.1089/thy.2021.0361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。